Search results for "Psychological tests"

showing 10 items of 594 documents

Cognitive impairment and consumption of mental healthcare resources in outpatients with bipolar disorder.

2020

Cognitive dysfunction is a major predictor of functional outcomes, and loss of occupational functioning is usually linked with a higher cost of illness. However, the association between cognitive impairment and consumption of health resources has not been studied in bipolar disorder to date. This study aims to examine this relationship. This is an observational, retrospective study of a representative sample of euthymic outpatients between 18 and 55 years, fulfilling DSM 5 criteria for bipolar disorder and recruited at a catchment area in Spain. Cognitive performance was screened with the Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S), and several variables of…

Mental Health Servicesmedicine.medical_specialtyBipolar DisorderNeuropsychological TestsDSM-503 medical and health sciences0302 clinical medicineQuality of life (healthcare)OutpatientsMedicineHumansCognitive DysfunctionEffects of sleep deprivation on cognitive performanceBipolar disorderPsychiatryBiological PsychiatryRetrospective Studiesbusiness.industryRetrospective cohort studyCognitionmedicine.disease030227 psychiatryPsychiatry and Mental healthSchizophreniaSpainObservational studybusinessCognition Disorders030217 neurology & neurosurgeryJournal of psychiatric research
researchProduct

Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models.

2012

Item does not contain fulltext The hippocampus is affected at an early stage in the development of Alzheimer's disease (AD). With the use of structural magnetic resonance (MR) imaging, we can investigate the effect of AD on the morphology of the hippocampus. The hippocampal shape variations among a population can be usually described using statistical shape models (SSMs). Conventional SSMs model the modes of variations among the population via principal component analysis (PCA). Although these modes are representative of variations within the training data, they are not necessarily discriminative on labeled data or relevant to the differences between the subpopulations. We use the shape des…

Models AnatomicMaleSupport Vector MachineDatabases FactualNeuropsychological TestsHippocampusFunctional Laterality030218 nuclear medicine & medical imagingLogical addressCorrelation0302 clinical medicineDiscriminative modelAlzheimer Centre [DCN PAC - Perception action and control NCEBP 11][ INFO.INFO-TI ] Computer Science [cs]/Image Processingeducation.field_of_studyBrain MappingPrincipal Component AnalysisVerbal LearningMagnetic Resonance ImagingNeurologyData Interpretation Statistical[INFO.INFO-TI]Computer Science [cs]/Image Processing [eess.IV]Principal component analysisEducational StatusFemalePsychologyCognitive NeurosciencePopulationFeature selectionVerbal learningStatiscal Shape Model03 medical and health sciencesAlzheimer DiseaseArtificial IntelligenceSupport Vector MachinesHumansAlzheimer Centre [NCEBP 11]educationAgedMemory DisordersNeurology & NeurosurgeryModels Statisticalbusiness.industryPattern recognitionSupport vector machineMental RecallAlzheimerArtificial intelligenceAtrophybusiness030217 neurology & neurosurgery
researchProduct

T-patterns in the study of movement and behavioral disorders

2020

Aim of the present review is to offer an outline of the application of T-pattern analysis (TPA) in the study of neurological disorders characterized by anomalies of movement and, more in general, of behavior. TPA is a multivariate technique to detect real time patterns of behavior on the basis of statistically significant constraints among the events in sequence. TPA is particularly suitable to analyse the structure of behavior. The application of TPA to study movement and behavioral disorders is able to offer, with a high level of detail, hidden characteristics of behavior otherwise impossible to detect. For its intrinsic features, TPA is completely different not only from quantitative eva…

Multivariate statisticsQuantitative EvaluationsExperimental and Cognitive PsychologyNeuropsychological TestsSettore BIO/09 - Fisiologia03 medical and health sciencesBehavioral NeuroscienceBehavior disorderTime pattern0302 clinical medicineAnimalsHumans0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyMultivariate techniqueMovement disorderMovement Disordersintegumentary systemMovement (music)Mental Disorders05 social sciencesT-pattern analysiMultivariate AnalysisBehavioral disorderTPATransition matricesPsychologyAlgorithms030217 neurology & neurosurgeryCognitive psychology
researchProduct

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.

2011

Abstract Background Different factors may influence cognitive functioning in bipolar disorder such as the effect of subsyndromal symptoms, the history of psychotic symptomatology or substance abuse, negative symptomatology, chronicity, sleep disturbances, and hormonal factors. The effect of pharmacologic treatment on cognition is still uncertain because of an insufficient number of studies examining this issue. Objective The aims of this study were to compare neuropsychologic performance of treated bipolar patients with that of controls, including unmedicated patients and healthy subjects, as well as to evaluate possible neurocognitive differences among 3 different atypical antipsychotics. …

OlanzapineAdultMalemedicine.medical_specialtyDibenzothiazepinesBipolar DisorderAdolescentlcsh:RC435-571medicine.drug_classmedicine.medical_treatmentEmotionsAtypical antipsychoticNeuropsychological TestsYoung Mania Rating ScaleBenzodiazepinesExecutive FunctionQuetiapine FumarateYoung AdultCognitionMemorylcsh:PsychiatrymedicineHumansAttentionBipolar disorderPsychiatryAntipsychoticPsychiatric Status Rating ScalesRisperidoneCalifornia Verbal Learning TestMiddle Agedmedicine.diseaseRisperidonePsychiatry and Mental healthClinical PsychologyOlanzapineCase-Control StudiesQuetiapineFemalePsychologymedicine.drugClinical psychologyAntipsychotic AgentsComprehensive psychiatry
researchProduct

Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.

2012

Abstract Background Imaging evidence indicates that brain alterations are primary to the full-blown onset of schizophrenia and seem to progress across time. The potential effects of antipsychotic medication on brain structure represent a key factor in understanding brain changes in psychosis. We aimed to investigate the effects of low doses of haloperidol, risperidone and olanzapine on cortical thickness. Method We investigated the effects of risperidone (N = 16), olanzapine (N = 18) and low doses of haloperidol (N = 18) in cortical thickness changes during 1-year follow-up period in a large and heterogeneous sample of schizophrenia spectrum patients. The relationship between cortical thick…

OlanzapineAdultMalemedicine.medical_specialtyPsychosisAdolescentmedicine.medical_treatmentNeuropsychological TestsBenzodiazepinesYoung AdultDouble-Blind MethodInternal medicinemedicineHaloperidolImage Processing Computer-AssistedHumansAntipsychoticScale for the Assessment of Negative SymptomsBiological PsychiatryAgedRetrospective StudiesCerebral CortexPsychiatric Status Rating ScalesAnalysis of VarianceRisperidoneVoxel-based morphometryMiddle Agedmedicine.diseaseRisperidoneMagnetic Resonance ImagingPsychiatry and Mental healthEndocrinologyFrontal lobeOlanzapineSchizophreniaHaloperidolFemalePsychologyCognition Disordersmedicine.drugClinical psychologyAntipsychotic AgentsFollow-Up StudiesSchizophrenia research
researchProduct

Brain-derived neurotrophic factor correlates with functional and cognitive impairment in non-disabled older individuals.

2015

We used a complete battery of geriatric and psychometric tests to evaluate whether plasma-borne brain-derived neurotrophic factor (BDNF), a master molecule in neuroplasticity, is associated with the severity of functional and cognitive impairment in non-disabled older individuals. There was a significant positive correlation between BDNF plasma concentrations and the Barthel index, a measurement of the ability of individuals to perform the activities of daily living (p=0.03) and the concentration subcategory measured with the mini mental state examination (MMSE) test (p = 0.01). Furthermore, plasma BDNF inversely and significantly correlated with the blood eosinophil count (p = 0.01), the t…

OncologyMaleAgingmedicine.medical_specialtyActivities of daily livingFrail ElderlyNeuropsychological TestsBiochemistryEndocrinologyCognitionNeurotrophic factorsInternal medicineNeuroplasticityActivities of Daily LivingGeneticsMedicineHumansPsychiatryMolecular BiologyGeriatric AssessmentAgedBrain-derived neurotrophic factorAged 80 and overMini–Mental State Examinationmedicine.diagnostic_testbusiness.industryBrain-Derived Neurotrophic FactorCognitionCell BiologyMiddle AgedPathophysiologyCross-Sectional StudiesSpainLinear ModelsBiomarker (medicine)FemalebusinessCognition DisordersBiomarkersExperimental gerontology
researchProduct

Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort

2020

PURPOSE The HIT-2000-BIS4 trial aimed to avoid highly detrimental craniospinal irradiation (CSI) in children < 4 years of age with nonmetastatic medulloblastoma by systemic chemotherapy, intraventricular methotrexate, and risk-adapted local radiotherapy. PATIENTS AND METHODS From 2001-2011, 87 patients received systemic chemotherapy and intraventricular methotrexate. Until 2006, CSI was reserved for nonresponse or progression. After 2006, local radiotherapy was introduced for nonresponders or patients with classic medulloblastoma (CMB) or large-cell/anaplastic medulloblastoma (LCA). DNA methylation profiles of infantile sonic hedgehog-activated medulloblastoma (SHH-INF) were subdivided i…

OncologyMaleCancer ResearchMedizinradiotherapy [Medulloblastoma]Neuropsychological Testsadverse effects [Cranial Irradiation]Craniospinal Irradiation0302 clinical medicinemortality [Cerebellar Neoplasms]drug therapy [Medulloblastoma]Early childhoodProspective Studiesddc:618Systemic chemotherapyCerebellar Neoplasms / mortality3. Good healthOncology030220 oncology & carcinogenesisChild PreschoolMedulloblastoma / radiotherapyFemalemortality [Medulloblastoma]medicine.medical_specialtyCerebellar Neoplasms / drug therapyCerebellar Neoplasms / radiotherapyMEDLINEMedulloblastoma / drug therapyadministration & dosage [Methotrexate]03 medical and health sciencesInternal medicinedrug therapy [Cerebellar Neoplasms]medicineHumansddc:610Cerebellar NeoplasmsMedulloblastomaCranial Irradiation / adverse effectsbusiness.industryEditorialsInfantMethotrexate / administration & dosageDNA Methylationmedicine.diseaseClinical trialMethotrexateMedulloblastoma / mortalityradiotherapy [Cerebellar Neoplasms]Cranial IrradiationbusinessValidation cohort030217 neurology & neurosurgeryMedulloblastoma
researchProduct

Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current trea…

2018

Approved medications for relapsing-remitting multiple sclerosis have shown to be effective in terms of their anti-inflammatory potential. However, it is also crucial to evaluate what long-term effects a patient can expect from current MS drugs in terms of preventing neurodegeneration. Here we aim to provide an overview of the current treatment strategies in MS with a specific focus on potential neuroprotective effects. Areas covered: Randomized, double-blind and placebo or referral-drug controlled phase 2a/b and phase 3 trials were examined; non-blinded phase 4 studies (extension studies) were included to provide long-term data, if not otherwise available. Endpoints considered were expanded…

Oncologymedicine.medical_specialtyAnti-Inflammatory AgentsNeuroimagingDiseaseNeuropsychological TestsPlaceboNeuroprotectionDisability Evaluation03 medical and health scienceschemistry.chemical_compoundMultiple Sclerosis Relapsing-Remitting0302 clinical medicineInternal medicineTeriflunomidemedicineHumansPharmacology (medical)030212 general & internal medicineNeuronsExpanded Disability Status Scalebusiness.industryGeneral NeuroscienceMultiple sclerosismedicine.diseaseMagnetic Resonance ImagingFingolimodNeuroprotective AgentsTreatment OutcomeMultiple sclerosis functional compositechemistryDisease ProgressionNeurology (clinical)businessImmunosuppressive Agents030217 neurology & neurosurgerymedicine.drugExpert Review of Neurotherapeutics
researchProduct

Auditory and Cognitive Deficits Associated with Acquired Amusia after Stroke: A Magnetoencephalography and Neuropsychological Follow-Up Study

2010

Acquired amusia is a common disorder after damage to the middle cerebral artery (MCA) territory. However, its neurocognitive mechanisms, especially the relative contribution of perceptual and cognitive factors, are still unclear. We studied cognitive and auditory processing in the amusic brain by performing neuropsychological testing as well as magnetoencephalography (MEG) measurements of frequency and duration discrimination using magnetic mismatch negativity (MMNm) recordings. Fifty-three patients with a left (n = 24) or right (n = 29) hemisphere MCA stroke (MRI verified) were investigated 1 week, 3 months, and 6 months after the stroke. Amusia was evaluated using the Montreal Battery of …

PITCHMalemagnetoencephalographyMiddle Cerebral ArteryAnatomy and Physiologylcsh:MedicineMismatch negativity312 Clinical medicineNeuropsychological TestsAudiologymagnetic fieldsCardiovascularSocial and Behavioral SciencesBehavioral NeuroscienceLearning and MemoryCognition0302 clinical medicinePsychologyMedicinelcsh:Sciencemagnetoencephalography and neuropsychologicalClinical NeurophysiologyMultidisciplinarymedicine.diagnostic_testBRAIN RESPONSES05 social sciencesStroke RehabilitationCognitive flexibilityNeuropsychologyMagnetoencephalographyElectroencephalographyExperimental Psychologyfollow-up studyMiddle Aged3. Good healthElectrophysiologyStrokeHemorrhagic StrokeClinical PsychologyMemory Short-TermNeurologyMedicineSensory PerceptionFemaleMUSIC PERCEPTION DEFICITSResearch ArticleAdultCORTEXmedicine.medical_specialtyMISMATCH NEGATIVITY MMN515 PsychologyCognitive NeuroscienceCerebrovascular DiseasesNeuroimagingAmusiaAuditory cortex050105 experimental psychologyLateralization of brain functionPerceptual Disorders03 medical and health sciencesNeuropsychologyDiagnostic MedicineSPEECH INTONATIONHumans0501 psychology and cognitive sciencesBiologyMusic TherapyIschemic StrokeAuditory CortexCONGENITAL AMUSIAbusiness.industryMEMORYlcsh:R3112 NeurosciencesMagnetoencephalographymedicine.diseaseAuditory and cognitive deficits6131 Theatre dance music other performing artsNeuroanatomyDISCRIMINATIONBrain Injurieslcsh:QNEURAL-NETWORKSbusinessNeurocognitive030217 neurology & neurosurgeryNeuroscienceFollow-Up Studies
researchProduct

Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration

2005

Background: Frontotemporal lobar degeneration (FTLD) may be inherited as an autosomal dominant disease. Studying patients "at risk" for developing FTLD can provide insights into the earliest onset and evolution of the disease. Method: We carried out approximately annual clinical, MRI, and neuropsychological assessments on an asymptomatic 51 year old "at risk" family member from a family with FTLD associated with ubiquitin-positive and tau-negative inclusion bodies. We used non-linear (fluid) registration of serial MRI to determine areas undergoing significant regional atrophy at different stages of the disease. Results: Over the first 26 months of the study, the patient remained asymptomati…

PaperMalePathologymedicine.medical_specialtyDiseaseNeuropsychological TestsAsymptomaticBrain mappingAtrophy Brain/pathology Brain Mapping Dementia/pathology Disease Progression Female Follow-Up Studies Humans Male Middle Aged Neuropsychological TestsAtrophymental disordersmedicineHumansDementiaBrain MappingSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaNeuropsychologyfood and beveragesnutritional and metabolic diseasesBrainAutosomal dominant traitFrontotemporal lobar degenerationMiddle Agedmedicine.diseasenervous system diseasesPsychiatry and Mental healthDisease ProgressionDementiaFemaleSurgeryNeurology (clinical)Atrophymedicine.symptomPsychologyFollow-Up Studies
researchProduct